|
Septicemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
Toll receptors and sepsis.
|
11805536 |
2001 |
|
Septicemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our study investigated the association between TLR4 mutations (Asp299Gly and Thr399Ile) and CD14 polymorphism(s) with outcome in an intensive care unit (ICU) population at risk for sepsis.
|
12404174 |
2002 |
|
Septicemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
We adapted template-directed dye-terminator incorporation with fluorescence polarization detection (TDI-FP) to the analysis of eight SNPs implicated in mediating the sepsis syndrome: TNF-alpha (-308), TNF-alpha (-238), TNF-beta (+250), IL-1beta (+3953), IL-6 (-174), IL-10 (-592), plasminogen activator inhibitor-1 (PAI-1 (-675)), and TLR4 299 (+1032).
|
12411588 |
2002 |
|
Septicemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Serum levels of tumour necrosis factor, interleukin (IL)-10, and IL-6 at sepsis onset did not significantly differ between patients carrying wild-type and mutant TLR4.
|
12807489 |
2003 |
|
Septicemia
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Although TLR-4 mRNA expression in healthy control monocytes could be modulated in vitro by culture with lipopolysaccharide or interleukin-10, this was not observed in monocytes obtained from sepsis and ITU control subjects, suggesting that septic and ITU control milieus may alter the immunoregulation of TLR-4 mRNA expression on monocytes.
|
15086396 |
2004 |
|
Septicemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
Freshly isolated PMN from patients with sepsis exhibited significantly (P < 0.05) higher mean fluorescence for TLR-2 (78.0 +/- 18.6) and TLR-4 (11.4 +/- 2.3) than controls (12.8 +/- 2.2 and 2.3 +/- 0.4).
|
15489631 |
2004 |
|
Septicemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Candidate single nucleotide polymorphisms (SNPs) within bacterial recognition (TLR4 +896, CD14 -159) and inflammatory response (TNF-alpha -308, IL-1beta -31, IL-6 -174) loci were evaluated for association with increased risk for severe sepsis (sepsis plus organ dysfunction or septic shock) and mortality.
|
15520404 |
2004 |
|
Septicemia
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
The IL-1 receptor-associated kinase (IRAK-1) plays a central role in TLR2- and TLR4-induced activation of nuclear factor (NF)-kappaB, a critical event in the transcriptional regulation of many sepsis-associated proinflammatory mediators.
|
16528020 |
2006 |
|
Septicemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Candidate genes for asthma and allergic diseases co-associated with sepsis including innate immunity receptors and related molecules (CD14, TLR4 and AOAH) and novel genes such as MYLK provide good examples of pleitropic effects of innate immunity genes, where variants conferring risk to specific traits (i.e. sepsis) under one set of genetic and environmental circumstances confer a reduced risk in a different (but possibly related) clinical outcome (i.e. allergic asthma), and support the 'common variant/multiple disease' hypothesis.
|
17989521 |
2007 |
|
Septicemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Two commonly occurring SNPs in the human TLR4 gene (Asp299Gly and Thr399Ile) have been shown to be associated with increased risk of Gram-negative bacteremia in sepsis patients and with susceptibility to inflammatory bowel disease.
|
18034244 |
2008 |
|
Septicemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Adjusting for independent risk factors, carriage of the variant TLR4 896 G allele was associated with decreased risk of complicated sepsis (odds ratio = 0.3, 95% confidence interval, 0.1-0.7, p = 0.008).
|
19131814 |
2009 |
|
Septicemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
To validate the concept of TLR4-targeted treatment strategies in gram-negative sepsis, we first showed that TLR4(-/-) and myeloid differentiation primary response gene 88 (MyD88)(-/-) mice were fully resistant to Escherichia coli-induced septic shock, whereas TLR2(-/-) and wild-type mice rapidly died of fulminant sepsis.
|
19181857 |
2009 |
|
Septicemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Combined with our previous in vitro functional study, the results suggest that the TLR4 11367 polymorphism might be a good predictor of who is more likely to develop complications such as sepsis or multiple organ dysfunction syndrome, depending on genotype.
|
20026833 |
2009 |
|
Septicemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The toll-like receptor 4/2242 polymorphism is a functional variant and might be used as a relevant risk estimate for organ dysfunction and sepsis in trauma patients.
|
20228685 |
2010 |
|
Septicemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Examples include variants of TLR4 in sepsis, malaria, inflammatory bowel disease and atherosclerosis; variants in TLR2 in tuberculosis and asthma; a variant in Mal (a key signal for TLR2 and TLR4) in malaria, tuberculosis and systemic lupus erythematosus; and variants in the kinase IRAK4 in pyogenic infections.
|
20375592 |
2009 |
|
Septicemia
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
HES could ameliorate BBB dysfunction and inflammation mediators by modulating brain TLR2 and TLR4 expression during sepsis.
|
20451670 |
2010 |
|
Septicemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release: an observational study in three cohorts.
|
20525286 |
2010 |
|
Septicemia
|
0.400 |
Biomarker
|
disease |
CTD_human |
Innate immunity and inflammation in sepsis: mechanisms of suppressed host resistance in mice treated with ethanol in a binge-drinking model.
|
20624996 |
2010 |
|
Septicemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
We conclude that TLR4 stimulation and human sepsis activate pathways that couple NAD(+) and its sensor SIRT1 with epigenetic reprogramming.
|
21245135 |
2011 |
|
Septicemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
In vivo, ES-62 protected mice against endotoxic and polymicrobial septic shock by TLR4-mediated induction of autophagy and was protective even when administered after the induction of sepsis.
|
21358639 |
2011 |
|
Septicemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, differences in distribution of TLR4 polymorphisms Asp299Gly and Thr399Ile in European populations are most likely due to a combination of population migration events combined with selection due to sepsis.
|
21968286 |
2012 |
|
Septicemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
Collectively, the results from the current study demonstrate CD16 as a key regulator of the TRIF-dependent TLR4 pathway in human monocytes and their CD16-expressing subset, with implications in sepsis.
|
22427642 |
2012 |
|
Septicemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Some, but not all, epidemiological studies have suggested that Toll-like receptor 4 (TLR4) polymorphisms, Asp299Gly and Thr399Ile, may influence the risk of at-risk patients for sepsis.
|
22537674 |
2012 |
|
Septicemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Consequently, this study was not able to detect associations between TLR4 polymorphisms and sepsis in this population.
|
23871732 |
2013 |
|
Septicemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
Inhibition of this late-phase pathway reduced the extent of TNF-α production by mouse macrophages exposed to the TLR4 ligand lipopolysaccharide (LPS) and ameliorated LPS-induced sepsis in mice.
|
24084649 |
2013 |